Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials? uri icon

authors

  • Fountzilas, Christos
  • Mahalingam, Devalingam
  • Stuart, Selena
  • Hernandez, Brian
  • Bowhay-Carnes, Elizabeth
  • Michalek, Joel
  • Sarantopoulos, John
  • Karnad, Anand
  • Patel, Sukeshi
  • Weitman, Steven

publication date

  • January 19, 2017